Allied Research Directors Re-Elected
TM Capital assisted the Board of Directors of Allied Research Corporation (AMEX) in connection with a proxy contest in which all of Allied’s directors were successfully re-elected
TAB Products Adopts Rights Plan
TM Capital assisted the Board of Directors of TAB Products, Inc. (AMEX) in adopting a shareholder’s rights plan.
Atlantic Acquired by J.F. Lehman
TM Capital assisted the Board of Directors of Atlantic Marine Holding Company in the evaluation of the acquisition by J.F. Lehman & Company
BlueLinx Proposes Reverse Stock Split
TM Capital served as financial advisor to BlueLinx Holdings Inc. (NYSE:BXC) in connection with its proposed 1 for 10 reverse stock split
Teknowledge Adopts Rights Plan
TM Capital assisted the Board of Directors of Teknowledge, Inc. (NASDAQ) in adopting a shareholder’s rights plan.
PSC Completes Restructuring
TM Capital served as financial advisor to a bank group led by Fleet National Bank regarding a senior credit facility with PSC Inc. (NASDAQ)
Omega Completes Share Repurchase
TM Capital was retained by the Board of Directors of Omega Protein (NYSE) to act as financial advisor in connection with Omega’s $47.5 million share repurchase from Zapata Corporation (NYSE)
RTC Completes Equity Valuation
TM Capital served as exclusive financial advisor to RTC, Inc. regarding an equity valuation and share repurchase
Magellan Petroleum Tender Defense
TM Capital advised the Board of Directors of Magellan Petroleum Corp. (NASD) in its successful defense against an unsolicited tender offer by SAGASCO Holdings Ltd. of Australia
SteriGenics Acquired by IBA
TM Capital completed the sale of SteriGenics International, Inc. (NASDAQ) to Ion Beam Applications s.a. of Belgium for $214 million in cash